Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 24 May 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Screening men for aortic aneurysms justified and cost effective

The English authors of a study in this week's issue of the Lancet provide evidence that screening men over 65 could substantially reduce death from ruptured aortic aneurysms.

News image

fiogf49gjkf04

Rupture of an aortic aneurysm (a swelling in the main blood vessel from the heart) is a major cause of death among men over 65 years of age.

However, opinion is divided as to whether ultrasound screening could be effective in preventing death from ruptured aneurysms.

The Multicentre Aneurysm Screening Study (MASS) led by Alan Scott from St Richards Hospital, Chichester, UK, compared the effect of screening for aortic aneurysms among a population of 67,800 men, aged 65 years or over.

The researchers invited half the study participants to attend screening, while the other half were a control group not invited for screening.

Men who had aneurysms detected by screening (swellings larger than 3cm diameter) were followed up for an average of 4 years, with surgical intervention when specific criteria were reached.

The research team found that the relative risk of aneurysm-related death was reduced by around 50% among men who were screened, and around 40% in those who were invited for screening (65 compared with 113 deaths).

The absolute risk of these men dying from aortic aneurysms was around 2 per 1000 compared with just over 3 per 1000 for men in the control group.

Clinical and economic analysis provide clear evidence to support screening in elderly men.
BMJ
The team calculated that 710 men would need to be screened to prevent 1 aneurysm-related death.

In addition, 30-day death rates were 6% after elective surgery for an aneurysm, compared with 37% after emergency surgery (a more likely outcome for the men who were not screened).

Mr Scott commented, "Our results indicate that substantial reductions in aneurysm-related mortality could be achieved by the implementation of a population-screening programme”.

“In view of the much higher frequency of the condition among men, and the absence of evidence of effect of screening on the incidence of ruptured aneurysms in women, it would be logical to screen only men”.

“The suggestion in an earlier report that a national screening program could consist of a single aortic ultrasound scan at age 65 would be supported by our results."

Further analysis of the MASS trial is published in the latest British Medical Journal.

Researchers found routine screening for aortic aneurysms in older men to be cost effective.

Using data from the previously described trial, the research team assessed the cost effectiveness of ultrasound screening for abdominal aortic aneurysms in 67,800 men aged 65 to 74 years for up to 4 years.

Over 4 years, there were 47 fewer deaths related to abdominal aortic aneurysms in the screening group than in the control group, but the additional costs incurred were £2.2m (GBP).

After adjustment, the additional cost of the screening program was £63 per patient.

The cost effectiveness ratio was £28,400 per life year gained.

The team concludes, "The clinical analysis and this economic analysis of the MASS trial together provide clear evidence to support the cost effectiveness of this particular form of screening in elderly men".

Lancet 2002; 360(9345): 1531-9
15 November 2002

Go to top of page Email this page Email this page to a colleague

 24 May 2018 
Precision medicine for tumors
 24 May 2018 
Patient-reported outcome measures in IBD trials
 24 May 2018 
Alcohol consumption and outcomes in drug-induced liver injury
 23 May 2018 
High body mass index is and ulcerative colitis
 23 May 2018 
Management of perianal fistulas in Crohn’s disease
 23 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 22 May 2018 
Worldwide H.pylori prevalence
 22 May 2018 
PPI and risk of stroke
 22 May 2018 
Online tool predicts bowel dysfunction severity prior to anterior resection
 21 May 2018 
Fecal incontinence and quality of life in IBD
 21 May 2018 
PPI use and cognitive decline
 21 May 2018 
Depressive symptoms in IBD youth
 18 May 2018 
Esophageal dilatation in clinical practice 
 17 May 2018 
IBD and later extraintestinal manifestations
 17 May 2018 
Repeat stool DNA testing
 17 May 2018 
IBS and chronic fatigue following GI infection
 16 May 2018 
Factors associated with fecal incontinence
 16 May 2018 
Diagnostic delay in Crohn's disease
 16 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 15 May 2018 
Guidelines for management of Crohn's
 15 May 2018 
New therapies for CDI
 15 May 2018 
Hep B in the Grey Zone
 14 May 2018 
Blood test for the diagnosis of fibrotic NASH
 14 May 2018 
Outcomes at bariatric centers of excellence
 14 May 2018 
Management of perianal fistulas in Crohn’s
 11 May 2018 
Detection of undiagnosed celiac disease
 11 May 2018 
Alcohol consumption and drug-induced liver injury
 10 May 2018 
Colorectal cancer screening
 10 May 2018 
Post‐operative complications in elderly IBD
 10 May 2018 
Fibrosis in patients with chronic hepatitis B
 09 May 2018 
Esophageal dilatation in clinical practice 
 09 May 2018 
Fecal incontinence
 09 May 2018 
Health problems and IBS
 07 May 2018 
Omitting antibiotics in uncomplicated acute diverticulitis
 07 May 2018 
Health problems and IBS
 07 May 2018 
Assessment of diminutive colorectal polyps
 04 May 2018 
Factors associated with fecal incontinence
 04 May 2018 
National Institutes of Health workshop and obesity
 04 May 2018 
Colorectal cancer screening and ethnic inequities
 03 May 2018 
Gastrointestinal ultrasound in IBD
 03 May 2018 
Ultransonography in postsurgical recurrence in Crohn's
 02 May 2018 
Hep C antiviral treatment and liver cancer risk
 02 May 2018 
Symptom assessment in cirrhotic ascites
 02 May 2018 
Chronic Hep B
 01 May 2018 
European guidelines on pancreatic cystic neoplasms
 01 May 2018 
Interferon‐free regimens in Hep C
 01 May 2018 
Age at IBD onset and extraintestinal complications
 30 April 2018 
Formula for preterm infants
 30 April 2018 
Primary antibiotic resistance and sequential therapy for H. pylori
 27 April 2018 
Eastern and western practices for endoscopic resection of colorectal lesions
 27 April 2018 
Anxiety scale for chronic esophageal disease
 27 April 2018 
Disease activity in eosinophilic esophagitis
 26 April 2018 
Obesity and physical activity in diverticulosis
 26 April 2018 
Primary sclerosing cholangitis in the USA
 25 April 2018 
Aspirin and pancreatic cancer
 25 April 2018 
Central mediators of irinotecan-induced steatohepatitis
 25 April 2018 
Neuroimaging in Hep C
 24 April 2018 
Scoring system identifies cancer risk in Barrett's
 24 April 2018 
Microbiome in athletes vs sedentary subjects
 23 April 2018 
Genome-wide study on HBV-related acute-on-chronic liver failure

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us